Skip Navigation


NDT Advance Access originally published online on February 19, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/5/1106    most recent
gfh127v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chen, Y.-M.
Right arrow Articles by Tsai, T.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.-M.
Right arrow Articles by Tsai, T.-J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2004) 19: 1106-1115
Nephrol Dial Transplant Vol. 19 No. 5 © ERA-EDTA 2004; all rights reserved

Original Article

Pentoxifylline suppresses renal tumour necrosis factor-{alpha} and ameliorates experimental crescentic glomerulonephritis in rats

Yung-Ming Chen1, Yee-Yung Ng2, Shuei-Liong Lin2, Wen-Chih Chiang2, Hui Y. Lan3 and Tun-Jun Tsai1

1Department of Medicine, National Taiwan University Hospital and College of Medicine National Taiwan University, 2Veterans General Hospital, Yang-Ming University, Taipei, 10016, Taiwan and 3Department of Medicine-Nephrology, Baylor College of Medicine, Houston, USA

Correspondence and offprint requests to: Dr Tun-Jun Tsai, Department of Medicine, National Taiwan University Hospital, College of Medicine National Taiwan University. No. 7, Chung-Shan South Road, Taipei, 10016, Taiwan. Email: paul{at}ha.mc.ntu.edu.tw

Background. Crescentic glomerulonephritis is a rapidly progressive form of glomerulonephritis, but treatment remains non-specific. The methylxanthine derivative pentoxifylline (PTX) is a clinically available phosphodiesterase inhibitor with anti-inflammatory and immunoregulatory activities. This study examined whether PTX has beneficial effects in a rat model of anti-glomerular basement membrane (GBM) crescentic glomerulonephritis.

Methods. Experimental crescentic glomerulonephritis was induced in Wistar rats by intravenous injection of rabbit anti-rat GBM serum and treated with either vehicle (phosphate-buffered saline) or PTX (0.1 g/kg/day) intravenously on a daily basis. Groups of six animals were euthanized at days 3, 7, 14 or 28 after induction of disease. Effects of PTX on renal function, histology and expression of cytokines, chemokines and adhesion molecules were determined.

Results. Compared with the vehicle-treated nephritic rats, PTX treatment beginning at the start of the nephritis significantly suppressed mRNA expression of tumour necrosis factor (TNF)-{alpha}, but not interleukin-1ß, throughout the course of nephritis. Moreover, PTX decreased renal mRNAs for intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1), regulated on activation, normal T-cell expressed and secreted (RANTES) and osteopontin (OPN) at all time points examined. These effects were associated with a significant inhibition of macrophage and T-cell infiltration, a reduction of 24-h urinary protein excretion (50–75%, P<0.05), an improvement of histological damage including glomerular crescent formation (60–70%, P<0.01) and a decrease of cortical mRNAs for type I ({alpha}1) collagen and fibronectin. The efficacy of PTX could also be seen, though to a lesser extent, in rats with established nephritis.

Conclusions. PTX is an effective anti-inflammatory and immunomodulatory agent capable of suppressing rat crescentic glomerulonephritis. Inhibition of renal TNF-{alpha}, ICAM-1, RANTES, MCP-1 and OPN expression may be a mechanism whereby PTX suppresses progressive renal injury in rat crescentic glomerulonephritis.

Keywords: adhesion molecules and chemokines; crescents; glomerulonephritis; pentoxifylline; TNF-{alpha}


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
S. Lionaki, K. Siamopoulos, I. Theodorou, E. Papadimitraki, G. Bertsias, D. Boumpas, and J. Boletis
Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: a pilot study
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2144 - 2150.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. F. Navarro-Gonzalez and C. Mora-Fernandez
The Role of Inflammatory Cytokines in Diabetic Nephropathy
J. Am. Soc. Nephrol., March 1, 2008; 19(3): 433 - 442.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S.-L. Lin, R.-H. Chen, Y.-M. Chen, W.-C. Chiang, C.-F. Lai, K.-D. Wu, and T.-J. Tsai
Pentoxifylline Attenuates Tubulointerstitial Fibrosis by Blocking Smad3/4-Activated Transcription and Profibrogenic Effects of Connective Tissue Growth Factor
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2702 - 2713.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. F. Navarro, C. Mora, M. Muros, and J. Garcia
Additive Antiproteinuric Effect of Pentoxifylline in Patients with Type 2 Diabetes under Angiotensin II Receptor Blockade: A Short-Term, Randomized, Controlled Trial
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2119 - 2126.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.